“…PDOX models thus far developed are pancreatic [Fu et al, ; Hiroshima et al, ,, ], breast [Fu et al, ], ovarian [Fu and Hoffman, ], lung [Wang et al, ], cervical [Hiroshima et al, ; Murakami et al, ], colon [Fu et al, ; Metildi et al, ; Hiroshima et al, ], and stomach cancers [Furukawa et al, ], sarcoma [Hiroshima et al, ,; Kiyuna et al, ; Murakami et al, ,], and melanoma [Yamamoto et al, ; Kawaguchi et al, ,]. PDOX models of sarcoma that we have developed include undifferentiated pleomorphic sarcoma (UPS) [Murakami et al, ; Kiyuna et al, ], follicular dendritic cell sarcoma (FDCS) [Kiyuna et al, ], rhabdomyosarcoma (RMS) [Igarashi et al, ], Ewing's sarcoma [Murakami et al, ], and osteosaroma [Murakami et al, ]. The present manuscript describes a PDOX model of undifferentiated spindle‐cell sarcoma (USCS).…”